Inhibition of uncoating of poliovirus by arildone, a new antiviral drug.
about
Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the hostNeutralization of poliovirus by cell receptors expressed in insect cellsAnalysis of three structurally related antiviral compounds in complex with human rhinovirus 16A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71Structural factors that control conformational transitions and serotype specificity in type 3 poliovirusStructural studies of poliovirus mutants that overcome receptor defectsIn vitro studies of the antirhinovirus activity of soluble intercellular adhesion molecule-1In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drugPrevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drugIn vitro antiviral activity of the 6-substituted 2-(3',4'-dichlorophenoxy)-2H-pyrano[2,3-b]pyridines MDL 20,610, MDL 20,646, and MDL 20,957Oral efficacy of WIN 51711 in mice infected with human poliovirusInhibition of rotaviruses by selected antiviral substances: mechanisms of viral inhibition and in vivo activityPrevention of human poliovirus-induced paralysis and death in mice by the novel antiviral agent arildoneAntiviral activity and mechanism of action of 2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile (MDL-860).Antiviral activity of Win 41258-3, a pyrazole compound, against herpes simplex virus in mouse genital infection and in guinea pig skin infectionSCH 48973: a potent, broad-spectrum, antienterovirus compoundAn interaction between glutathione and the capsid is required for the morphogenesis of C-cluster enterovirusesChemotherapeuticsThe structure of the poliovirus 135S cell entry intermediate at 10-angstrom resolution reveals the location of an externalized polypeptide that binds to membranes.Molecular tectonic model of virus structural transitions: the putative cell entry states of poliovirusAntiviral agents targeted to interact with viral capsid proteins and a possible application to human immunodeficiency virus.In vitro and in vivo antipicornavirus activity of some phenoxypyridinecarbonitriles.Is the 135S poliovirus particle an intermediate during cell entry?Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradication.Enterovirus infection in Korean children and anti-enteroviral potential candidate agents.Activity of arildone with or without interferon against acute hemorrhagic conjunctivitis viruses in cell culture.A placebo-controlled trial of topical 8% arildone cream early in recurrent genital herpes.Disposition of arildone, an antiviral agent, after various routes of administrationThe poliovirus 135S particle is infectious.Long-distance correlations of rhinovirus capsid dynamics contribute to uncoating and antiviral activity.Mechanism of entry into the cytosol of poliovirus type 1: requirement for low pH.Nucleic acid detection systems for enteroviruses.Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature.WIN 51711-dependent mutants of poliovirus type 3: evidence that virions decay after release from cells unless drug is presentWIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14Effect of a capsid-stabilizing pyridazinamine, R 78206, on the eclipse and intracellular location of poliovirus.Mutations in VP1 of poliovirus specifically affect both encapsidation and release of viral RNA.Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding.Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptorRhodanine resistance and dependence of echovirus 12: a possible consequence of capsid flexibility.
P2860
Q23925011-8C0E3ED1-0D31-4CED-8D2B-A0C92FCEE6A5Q24655726-D88AB8AE-586C-4A52-A950-086B168B7D9FQ27620817-DF2C27DA-4B98-427E-809D-03AD78030408Q27677825-37857AFC-FB7F-4C77-9A9D-D4D2C3D26711Q27696730-0CF22153-DD33-429B-B4E1-EB4BE9C94E88Q27741535-5A854BD0-1087-4CB7-8A61-5917A14C9407Q28327736-2926B40F-3CE1-4151-9FA7-BDC049D383EEQ28360307-D2E02A76-9662-427E-B91E-DD638BD1C423Q28360421-5277B264-D1A5-4220-AFA1-88F7B5B39F0BQ28361851-9B9E56F8-8AE5-4C7B-B07D-B8277315340FQ28362056-BEEF9C5B-19A0-4F12-9430-7593A145AD7EQ28366158-44D1B6BA-BCEA-4A51-A11A-9A9A26EB9E90Q28367944-88470D85-8BB5-4D4D-B8C6-60C31505F114Q28367974-C3BE7865-A165-4D0A-83EB-F27170F72D5FQ28368021-6A5E9EC6-D2B7-46C1-BF56-70BCADA15DD9Q28378955-E6968F63-43DE-45C9-A406-7E0D029F797AQ28537710-28053ECF-864E-4E52-8D6C-D370D8190DF8Q30047670-3B4F2D75-92A4-4582-BDB7-7611B9B107BFQ30160232-697B9A34-6144-4F19-ADFA-61BEF72F4B27Q30175274-2730F6E8-0FD1-4A1E-A7F5-004EAD01FFDCQ30196123-C0C35C29-466D-4027-B6EF-302FD054BB38Q30451297-BF9689FE-5D4B-495D-BE14-372D4ACACB3BQ33874546-E4D274E2-5B86-45B7-9952-F0E4A7416A1EQ34443617-BB87950C-AAAF-415D-BD58-CA116A9F0E0AQ34469094-FD0C6F8A-2BB0-4B33-8E28-F328ED082101Q35647628-475531E1-14B2-44CE-8CE4-3F43393C00E4Q35648857-FA341676-8A01-4476-9A74-64A48DC3C165Q35716866-18323FD4-E5A6-425D-8D58-7407CBA6B4EDQ35870848-362BEE66-8693-4B53-AC7C-E951A826CEB8Q35887229-CB79E6E0-5E05-4D12-BCD6-3AEA7E222143Q36210544-D8A8EA5E-EE28-4528-9452-773CE0E9AD4EQ36401640-D5B9AC84-DCE6-4404-AEA8-58720A384FC5Q36634400-F14DCB1B-810D-44FC-9BED-626FD2B391B7Q36642840-65084959-A9D3-469C-BDE5-51A6753AE0B7Q36686686-175201DA-E4F9-499A-AF1D-1FF177E95AF0Q36687025-DDB50289-1B80-4273-8E30-E29B8BC9359DQ36798854-6DD69EB9-69A3-441B-B260-845215E9CB0DQ36805022-45702679-0E10-41C7-A590-48E520AD072EQ37639745-E6E57281-CEF6-4E44-A122-7BFD629D896EQ39878349-4F8F9DFB-F43E-4366-89C9-4EFD5FFE8C37
P2860
Inhibition of uncoating of poliovirus by arildone, a new antiviral drug.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Inhibition of uncoating of poliovirus by arildone, a new antiviral drug.
@en
type
label
Inhibition of uncoating of poliovirus by arildone, a new antiviral drug.
@en
prefLabel
Inhibition of uncoating of poliovirus by arildone, a new antiviral drug.
@en
P2093
P1433
P1476
Inhibition of uncoating of poliovirus by arildone, a new antiviral drug.
@en
P2093
Caliguiri LA
McSharry JJ
P304
P356
10.1016/0042-6822(79)90342-8
P407
P577
1979-09-01T00:00:00Z